ERRATUM in Wilderness Environ Med. 29/1

Abstract

Table 1 and Table 2 of the following article contained incorrect units.

Table 1

Laboratory findings of case 1 patient

	Day
Laboratory investigation	1	3	4	5	6	7	8	9	10	11	14
WBC (×10³μL⁻¹)	5.6	9.8		7	8.1	8.9	7.7	7.3	7.7	9.6
Neutrophils (%)	38.5	82.4		72	63.7	75.2	78.5	61.4	71.4	77.3
Lymphocytes (%)	52.6	9.9		23	15.6	10.8	16.9	20.7	11.2	18.7
Platelets (×10³ μL⁻¹)	221	62		34	26	63	91	129	261	319
Hb (g·dL⁻¹)	12.1	12.3		9.6	8.6	9	8.8	6.7	8.8	8.4
PCV (%)	37.1	37.3		29.3	26.2	26.9	25.9	20.6	27.2	24.2
MCV (normal 80–95.5 fL)	84.2	81.9		81.9	81.7	82.1	82.2	83.9	82.6	79.8
MCH (normal 27–31 Pg)	27.6	26.9		26.8	26.8	27.5	27.8	27.3	26.7	27.7
MCHC (normal 33–37 g·dL⁻¹)	32.8	32.9		32.7	32.8	33.5	33.8	32.6	32.3	34.7
RBC count (normal 4–6 × 10⁶ μL⁻¹)	4.4	4.5		3.5	3.2	3.2	3.1	2.4	3.2	3
MPV (normal 7.8–11 fL)	8.6	7.8		9.5	9.3	10.4	9.2	7.6	8.6	7.5
Serum creatinine (μmol·L⁻¹)	87	358.4	454	419	598	582.1	423	532	296.2	235	128
Blood urea (mmol·L⁻¹)	3.4	12.3	17.7	19	25.4	27.2	24.1	20.8	16.9	18.7	10.5
Na⁺ (mmol·L⁻¹)	137	140	135	134	134	132	126	131	137	128
K⁺ (mmol·L⁻¹)	3.8	4.5	4.4	6.2	4.9	5.4	4.1	4.3	4.3	4
PT (s)	12.7/12			12.7/12	13.2/12	13.6/12	16/12	13/ 12		14/12
INR	1.06			1.06	1.10	1.14	1.34	1.08		1.18
APTT (s)	27.6/30			27.6/30	28/ 30	27.7/30	30/ 30	30/ 30		21/ 30
SGOT (AST) [U·I⁻¹]	26		31.3	34	32.8	65.5	103	73	24	19
SGPT (ALT) [U·I⁻¹]	19		13.2	18	24.4	81.3	56	31	48.8	43
Total bilirubin (μmol·L⁻¹)		49.5	56.7	55	41.5	17.7	10.8	7.9	6.71	6.7
Direct bilirubin (μmol·L⁻¹)		10.5	16.4	14.1	12.3
ALP (U·I⁻¹)		151.5	148		182	195.7

WBC, white blood cells; Hb, hemoglobin; PCV, packed cell volume; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; RBC, red blood cell; MPV, mean platelet volume; Na⁺, blood sodium level; K⁺, potassium; PT, prothrombin time; INR, international normalized ratio; APTT, activated partial thromboplastin time; SGOT, serum glutamic-oxaloacetic transaminase; AST, aspartate aminotransferase; SGPT, serum glutamic pyruvic transaminase; ALT, alanine aminotransferase; ALP, alkaline phosphatase.

Table 2

Laboratory findings of case 2 and 3 patients

	Case 2 patient		Case 3 patient
Laboratory investigation	Day 1	Day 2	Day 1
WBC (×10³μL⁻¹)	7.4	7	5.8
Neutrophils (%)	74.2	46	36
Lymphocytes (%)	22.5	30.3	46.3
Platelets (×10³ μL⁻¹)	239	302	399
Hb (g·dL⁻¹)	13	12.1	10
PCV (%)	41.4	26.9	33
MCV (normal 80–95.5 fL)	86	87	80.3
MCH (normal 27–31 Pg)	27.1	28.5	24.4
MCHC (normal 33–37 g·dL⁻¹)	31.5	32.8	30.4
RBC count (normal 4–6 ×10⁶ μL⁻¹)	4.8	4.2	4.1
MPV (normal 7.8–11 fL)	7.8	8.5	8.1
Serum creatinine (μmol·L⁻¹)	87	95.5	78
Na⁺ (mmol·L⁻¹)	146	141	143
K⁺ (mmol·L⁻¹)	4.6	3.8	3.7
PT (s)	13/12		11/12
INR	1.08		0.9
SGOT (AST) [U·I⁻¹]	28		59
SGPT (ALT) [U·I⁻¹]	40		28
Total bilirubin (μmol·L⁻¹)	26.3		24.8

WBC, white blood cells; Hb, hemoglobin; PCV, packed cell volume; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; RBC, red blood cell; MPV, mean platelet volume; Na⁺, blood sodium level; K⁺, potassium; PT, prothrombin time; INR, international normalized ratio; SGOT, serum glutamic-oxaloacetic transaminase; AST, aspartate aminotransferase; SGPT, serum glutamic pyruvic transaminase; ALT, alanine aminotransferase.

Namal Rathnayaka RMMK, Ranathunga AN, Kularatne SAM, Rajapakse J, Ranasinghe S, Jayathunga R. Microangiopathic hemolytic anemia following three different species of hump-nosed pit viper (genus: Hypnale) envenoming in Sri Lanka. Wilderness Environ Med. 2018;29(1):94–101.

On page 95, Table 1, and on page 98, Table 2, in Platelets and RBC count, the units are presented as x 10³ g·uL^-1 and x 10⁶ g·uL^-1, respectively. The units should be x 10³µL^-1 and x 10⁶µL^-1.

Corrected tables appear below.